We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Xerox
XRX
$362M
| $5.75M | 0.02% |
1,528,219
+843,504
| +123% | +$3.73M |
|
402
Cricut
CRCT
$1.01B
| $5.7M | 0.02% |
906,141
+392,951
| +77% | +$2.3M |
|
403
Danaher
DHR
$139B
| $5.68M | 0.02% |
28,645
-5,584
| -16% | -$1.11M |
|
404
TripAdvisor
TRIP
$1.72B
| $5.67M | 0.02% |
348,413
-1,275,836
| -79% | -$22.3M |
|
405
Arcturus Therapeutics
ARCT
$165M
| $5.63M | 0.02% |
305,659
-189,632
| -38% | -$3.05M |
|
406
Excelerate Energy
EE
$1.19B
| $5.63M | 0.02% |
223,423
-32,583
| -13% | -$813K |
|
407
Weave Communications
WEAV
$560M
| $5.61M | 0.02% |
840,246
+113,617
| +16% | +$875K |
|
408
HUB Group
HUBG
$2.95B
| $5.6M | 0.02% |
162,569
+17,746
| +12% | +$634K |
|
|
NPKI
409
NPK International
NPKI
$1.05B
| $5.57M | 0.02% |
492,622
-1,968
| -0.4% | -$19.2K |
|
|
INGM
410
Ingram Micro Holding
INGM
$7.01B
| $5.52M | 0.02% |
256,880
+170,450
| +197% | +$3.46M |
|
|
411
Tractor Supply
TSCO
$16.5B
| $5.51M | 0.02% |
96,970
-2,666,471
| -96% | -$157M |
|
412
Energy Recovery
ERII
$415M
| $5.48M | 0.02% |
355,295
-69,320
| -16% | -$977K |
|
413
Real Brokerage
REAX
$366M
| $5.43M | 0.02% |
1,298,020
+276,165
| +27% | +$1.25M |
|
414
Conduent
CNDT
$259M
| $5.43M | 0.02% |
1,937,609
-16,856
| -0.9% | -$45.6K |
|
415
Worthington Enterprises
WOR
$2.77B
| $5.4M | 0.02% |
97,360
+9,672
| +11% | +$610K |
|
416
Simon Property Group
SPG
$77.3B
| $5.36M | 0.02% |
28,566
+25,311
| +778% | +$4.37M |
|
417
Rogers Corp
ROG
$2.11B
| $5.29M | 0.02% |
65,711
-337
| -0.5% | -$25.1K |
|
418
Sterling Infrastructure
STRL
$15.8B
| $5.28M | 0.02% |
15,552
+256
| +2% | +$72.7K |
|
419
Sprouts Farmers Market
SFM
$7.45B
| $5.28M | 0.02% |
48,496
-13,519
| -22% | -$1.97M |
|
420
OneSpan
OSPN
$597M
| $5.23M | 0.02% |
329,202
+317,335
| +2,674% | +$4.83M |
|
421
Daktronics
DAKT
$953M
| $5.13M | 0.02% |
245,047
| – | – |
|
422
Barrett Business Services
BBSI
$1.01B
| $5.06M | 0.02% |
114,261
-106,732
| -48% | -$4.89M |
|
|
REVG
423
DELISTED
REV Group
REVG
| $5.06M | 0.02% |
89,296
| – | – |
|
424
Sarepta Therapeutics
SRPT
$1.66B
| $5.06M | 0.02% |
262,331
+17,798
| +7% | +$317K |
|
425
Neurocrine Biosciences
NBIX
$18.3B
| $4.99M | 0.02% |
35,520
-18,480
| -34% | -$2.5M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.